ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

CVC Buys Evonik Stake

June 9, 2008 | APPEARED IN VOLUME 86, ISSUE 23

The private equity firm CVC Capital Partners has paid roughly $3.7 billion to acquire a 25.01% stake in Evonik Industries. Evonik's diverse portfolio includes the former Degussa chemical business plus real estate and energy generation holdings. Wilhelm Bonse-Geuking, chairman of the RAG Foundation, Evonik's owner, says he and his colleagues picked CVC from the handful of private equity firms bidding for the stake because it has extensive experience in the chemistry and energy sectors. He also pointed out that CVC has an experienced team in Germany. Steven Koltes, managing partner of CVC, says, "Evonik is an outstanding enterprise with an enormous future potential." Hubertus Schmoldt, chairman of the German chemical industry trade union, who has been deeply involved in the formation of Evonik as part of the RAG Foundation, welcomes the sale as "a first important step" in Evonik's plan, somewhat delayed, to list on the German stock exchange. The CVC purchase, Schmoldt notes, gives Evonik time to ready itself for an initial public offering and will facilitate further investment in the company.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment